SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union
April 27, 2025 10:35 ET | Source: SpringWorks Therapeutics, Inc. STAMFORD, Conn.,…
Dragonfly Energy Announces First Quarter 2025 Preliminary Net Sales and Adjusted EBITDA
RENO, Nev., April 23, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp.…
Glazing the Way: Bakery China 2025 Set to Strengthen Global Industry Ties
SHANGHAI, Feb. 27, 2025 /PRNewswire/ -- The 27th Bakery China, scheduled for…
WiSAs CES Partners Highlight WiSA E Software in Diverse Use Cases and Implementations Across the Audio Ecosystem
Innovative audio solutions empower partners to captivate consumers, unlocking fresh revenue streams…
WiSA Association Announces Groundbreaking Innovations for Wireless Audio at CES 2025
WiSA E-based Reference Designs, Cutting-Edge Mobile Apps, and the Revolutionary SoundSend E…
Hettich Brings the Charm of Magical Interior Experiences to AceTech Mumbai 2024
MUMBAI, India, Nov. 14, 2024 /PRNewswire/ -- As Mumbai anticipates the next…